When my kids were around seven, dry, itchy, eczema patches appeared behind their knees. A Chinese skin doctor told me eczema is “asthma of the skin.” It sounded strange at the time — neither child had breathing problems — but the idea stayed with me. Skin, like lungs, is an interface with the environment. What we breathe, what settles in our homes, the air pollution outside, even microplastics, all of it may shape how a child’s immune system learns to respond.
Now a new study from researchers at the Icahn School of Medicine at Mount Sinai, Weill Cornell Medicine, and collaborating institutions offers a biological explanation for why eczema so often begins in childhood. Published February 25 in Nature, considered the best science journal, on the planet, the research identifies a brief early-life window when the skin’s immune system is wired to overreact to allergens.
Eczema affects nearly one in four children and frequently appears in infancy. It can also precede asthma and food allergies, a progression sometimes called the “atopic march.” Until now, scientists have struggled to explain why allergic skin disease is so tightly linked to early childhood.
The team focused on dendritic cells, the immune sentinels in the skin that detect environmental triggers. In young mice, these cells behaved differently than in adults. They didn’t overreact to everything. But when exposed to common allergens such as dust mites and mold, infant mice developed strong skin inflammation, while adult mice did not.
The difference appears to lie in timing and immune programming.
“We found that allergy risk is shaped very early in life, when the skin’s immune system is biologically programmed to overreact to allergens, with important consequences for understanding how immune-mediated diseases emerge and should be treated,” said senior author Shruti Naik, PhD.
In early life, dendritic cells were unusually active and quick to trigger allergic inflammation. When researchers blocked this pathway, the young mice did not develop skin allergies. The team also discovered that infant mice lack normal levels of stress hormones that later help keep immune reactions in check, effectively removing a natural brake on inflammation.
Importantly, signs of the same immune activity were found in skin samples from children with early-onset eczema, but not in adults. That suggests this early-life immune window may also operate in humans.
“This work was only possible through a true clinic-to-lab collaboration—where insights from pediatric patients shaped the questions we asked in the lab,” said co-author Emma Guttman-Yassky, MD, PhD.
The findings reinforce something environmental health researchers have long argued: early life is not simply a smaller version of adulthood. It is a distinct biological phase with its own rules and vulnerabilities.
“Children are not simply small adults when it comes to immunity,” said Dr. Naik. “Their immune system follows a unique set of rules, and recognizing that difference is essential for understanding—and ultimately preventing—allergic, immune-driven diseases that begin in childhood.”
According to the Children’s Hospital of Los Angeles, “The skin is the largest organ in the body and plays many essential roles, including maintaining a protective barrier, providing immunity, and communicating with the outside world.”
To manage eczema the clinic suggests managing triggers like dry skin, heat, and allergens, alongside using thick, fragrance-free moisturizers, soap substitutes, and prescribed steroids to control symptoms. I did notice that my kids’ skin problems started when we were living in the Middle East when the air was polluted and the temperatures hot and dry.
Related: Air pollution causes asthma in Cairo
For Green Prophet readers, the takeaway is clear. The first years of life may represent a critical window when environmental exposures: dust, mold, indoor allergens, pollutants, microplastics, all shape immune trajectories in lasting ways. If scientists can find safe ways to calm this early-life immune pathway, it may be possible to prevent allergic disease before it spreads from the skin to the lungs or gut.
The study is titled “Peripheral immune-inducer (pii)-DCs drive early life allergic inflammation.”
